August 28, 2025 · Form 4 insider transaction
Reprogrammed Interchange LLC sold 806,351 shares of Vor Biopharma Inc. at $2.01 per share, a transaction worth $1.62M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was executed in multiple trades at prices ranging from $1.95 to $2.075. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.; The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.